Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Resuscitation Without Lung Injury
NCT04681638Phase 4Terminated
- Sponsor
- Coalition for National Trauma Research
- Start
- Aug 2022
- Primary completion
- Jun 2024
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of INTERCEPT Plasma in burn injury (2 arms), sponsored by Coalition for National Trauma Research. Primary endpoint: Total volume of all resuscitation fluids delivered between hours 0-24 postburn at 24 hours. Started Aug 2022; status: terminated.
02
Drugs
INTERCEPT Plasma
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT04681638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04681638.